Category: Include on Menu
-
Quantum Cyber Shares Jump After Launch of U.S. Defense-Focused Subsidiary (QUCY)
Stock Rallies on Defense Expansion Strategy Shares of Quantum Cyber (NASDAQ:QUCY) surged 22.3% in premarket trading on Monday after the company announced the creation of Quantum Drones Corporation, a newly formed wholly owned subsidiary incorporated in Nevada. The subsidiary is expected to act as the company’s operational platform for U.S.-based defense technology initiatives and future…
-
Sintana Energy Secures $11.5 Million to Fund Namibia Exploration Activity (SEI)
Capital Raise to Support Drilling and Acquisitions Sintana Energy (USOTC:SEUSF) (TSX-V:SEI) has conditionally raised US$11.5 million to finance an active exploration programme, including participation in the Chevron-operated Nabba-1 well located within Namibia’s PEL 90 licence area. The financing was completed at 22.5 pence per new common share on AIM and C$0.41 per share on the…
-
Gossamer Bio Shares Decline After Wider-Than-Expected Q1 Loss Despite Revenue Beat (GOSS)
Stock Slips Following Quarterly Results Gossamer Bio (NASDAQ:GOSS) shares fell 5.09% in premarket trading on Monday after the company reported a first-quarter loss that came in worse than analyst expectations, even as revenue significantly exceeded forecasts. The company posted an adjusted quarterly loss of -$0.20 per share for the period ended March 31, compared with…
-
TOYO Shares Climb After Strong Q1 Earnings Beat and Upbeat Full-Year Outlook (TOYO)
Revenue and Profit Surge in First Quarter TOYO Co. (NASDAQ:TOYO) shares gained 4.6% in premarket trading on Monday after the company delivered first-quarter results that comfortably exceeded expectations, supported by strong growth across its solar solutions business. The company reported adjusted earnings per share of $0.75 for the quarter ended March 31, 2026. Revenue jumped…
-
Jefferies Warns Mobileye Shares Could Fall 24% on Structural Challenges (MBLY)
Jefferies Starts Coverage With Underperform Rating Mobileye Global (NASDAQ:MBLY) faces potential downside risks tied to structural industry challenges and customer concentration, according to Jefferies, which initiated coverage on the stock with an “underperform” rating and an $8 price target. The target implies roughly 24% downside from the stock’s previous closing price of $10.53. Jefferies based…
-
Meta to Eliminate Around 8,000 Jobs as AI Investment Push Intensifies (META)
Workforce Reductions Set to Begin This Week Meta Platforms (NASDAQ:META) is reportedly preparing to cut approximately 8,000 jobs this week, equal to roughly 10% of its workforce, according to a CNBC report published Monday. The company has also reportedly scrapped plans to hire for about 6,000 vacant positions. The layoffs are expected to begin on…
-
Victoria’s Secret Defends Board as Proxy Battle Intensifies Ahead of Annual Meeting (VSCO)
Company Highlights Strong Shareholder Returns Under New Leadership Victoria’s Secret & Co. (NYSE:VSCO) released a letter to shareholders outlining its recent financial and operational progress as the company faces a proxy challenge from BBRC International Pte Limited ahead of its annual meeting scheduled for June 11. The retailer said total shareholder return has climbed 141%…
-
Pioneer Power Shares Drop After Q1 Earnings Miss Despite Revenue Beat (PPSI)
Stock Falls Following Quarterly Results Shares of Pioneer Power Solutions (NASDAQ:PPSI) declined 6% in premarket trading on Monday after the company posted a wider-than-expected first-quarter loss, even as revenue came in above analyst forecasts. The company reported an adjusted quarterly loss of -$0.23 per share for the period ended March 31, missing Wall Street expectations…
-
Design Therapeutics Shares Jump on Encouraging Friedreich Ataxia Trial Results (DSGN)
Stock Surges Following Positive Clinical Update Shares of Design Therapeutics (NASDAQ:DSGN) climbed 27% on Monday after the company released favorable four-week data from its RESTORE-FA clinical trial evaluating DT-216P2 in patients with Friedreich ataxia. The biotechnology company said the treatment produced dose-dependent improvements across several clinical measurements while also increasing endogenous frataxin mRNA and protein…
-
Hims & Hers Shares Slide After Convertible Notes Offering Announcement (HIMS)
Stock Drops Following Financing Plan Shares of Hims & Hers Health (NYSE:HIMS) fell 7% on Monday after the company revealed plans to issue $300 million of convertible senior notes due in 2032 to qualified institutional investors. Company Targets Expansion and Infrastructure Investment Hims & Hers said the proceeds from the offering are intended to maintain…